Forte Biosciences, Inc. (FBRX)
20.33
+0.26
(+1.30%)
USD |
NASDAQ |
May 20, 16:00
20.34
+0.01
(+0.05%)
After-Hours: 16:38
Forte Biosciences EPS Diluted (Quarterly) : -1.241 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.14M |
| Total Expenses (Quarterly) | 22.14M |
| Enterprise Value | 352.79M |
| Earnings Yield | -25.12% |
| Normalized Earnings Yield | -25.12 |